Biography and Research Information
OverviewAI-generated summary
Erika Horta investigates human immune responses and their role in disease, with a focus on regulatory B cells and their interaction with macrophages. Her recent work has explored how specific human B cell populations, characterized by CD24+CD38+ expression, can influence macrophage function. This interaction is mediated through the synergistic effects of Interleukin-10 (IL-10) and the programmed death-ligand 1 (PD-L1) pathway, suggesting a mechanism for modulating inflammatory processes.
Her research also extends to clinical applications, including the pharmacological treatment of various conditions. Publications include studies on the efficacy of belzutifan for retinal capillary hemangioblastomas, everolimus for refractory seizures in tuberous sclerosis, and a review of current and future pharmacological treatments for brain metastases. Additionally, she has examined the prevalence of cerebrovascular accidents in patients with ulcerative colitis and contributed to the understanding of functional precision medicine assays for recurrent meningioma and high-grade glioma.
Metrics
- h-index: 7
- Publications: 41
- Citations: 479
Selected Publications
-
CTNI-03. REPLICATION-COMPETENT ADENOVIRUS-MEDIATED DOUBLE SUICIDE GENE THERAPY WITH FRACTIONATED STEREOTACTIC RADIOSURGERY IN PROGRESSIVE GLIOBLASTOMA: A PHASE 1 TRIAL (2025)
-
QLTI-06. Ophthalmologic Manifestations in Adults with Phakomatoses: A Retrospective Review (2025)
-
Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist (2025)
-
Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case (2024)
-
Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series (2024)
-
Diffuse Leptomeningeal Glioneuronal Tumor: First Description of Metastasis to the Lung and Bone Marrow (2023)
-
Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002) (2022)
-
NCMP-15. A CASE OF SYSTEMIC METASTATIC DIFFUSE LEPTOMENINGEAL GLIONEURAL TUMOR (2022)
-
Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system (2022)
-
Brain Metastases: Current and Future Pharmacological Treatment (2022)
-
Prevalence of Cerebrovascular Accidents in Patients with Ulcerative Colitis in a Single Academic Health System (2021)
Collaboration Network
Top Collaborators
- Diffuse Leptomeningeal Glioneuronal Tumor: First Description of Metastasis to the Lung and Bone Marrow
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- NCMP-15. A CASE OF SYSTEMIC METASTATIC DIFFUSE LEPTOMENINGEAL GLIONEURAL TUMOR
- Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Data from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Supplementary Methods, Tables 1 - 2 from Neural Autoantibody Clusters Aid Diagnosis of Cancer
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist
- Operative planning for a functional precision medicine assay of recurrent high-grade glioma: illustrative case
- Functional precision medicine assay for recurrent meningioma: a proof of principle. Illustrative case
- Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist
- Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review
- Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review
- Targeting BRAF V600E in Papillary Craniopharyngioma: Clinical Efficacy and Safety of Combined Braf-Mek Inhibition
- Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review
- Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review
- Targeting BRAF V600E in Papillary Craniopharyngioma: Clinical Efficacy and Safety of Combined Braf-Mek Inhibition
- Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system
- Prevalence of Cerebrovascular Accidents in Patients with Ulcerative Colitis in a Single Academic Health System
- Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system
- Prevalence of Cerebrovascular Accidents in Patients with Ulcerative Colitis in a Single Academic Health System
- Prevalence of cerebrovascular accidents in patients with ulcerative colitis in a single academic health system
- Prevalence of Cerebrovascular Accidents in Patients with Ulcerative Colitis in a Single Academic Health System
Similar Researchers
Based on overlapping research topics